WO2010013474A1 - セラミド産生促進剤 - Google Patents

セラミド産生促進剤 Download PDF

Info

Publication number
WO2010013474A1
WO2010013474A1 PCT/JP2009/003605 JP2009003605W WO2010013474A1 WO 2010013474 A1 WO2010013474 A1 WO 2010013474A1 JP 2009003605 W JP2009003605 W JP 2009003605W WO 2010013474 A1 WO2010013474 A1 WO 2010013474A1
Authority
WO
WIPO (PCT)
Prior art keywords
carbon atoms
production promoter
group
ceramide
ceramide production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2009/003605
Other languages
English (en)
French (fr)
Inventor
由也 菅井
宙 橋本
新哉 天野
正太郎 伊藤
芳枝 下豊留
頼子 中桐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2008197958A external-priority patent/JP5328254B2/ja
Priority claimed from JP2008197959A external-priority patent/JP5527952B2/ja
Application filed by Kao Corp filed Critical Kao Corp
Priority to US13/001,701 priority Critical patent/US8440645B2/en
Priority to CN2009801205557A priority patent/CN102438629A/zh
Publication of WO2010013474A1 publication Critical patent/WO2010013474A1/ja
Anticipated expiration legal-status Critical
Priority to US13/870,315 priority patent/US20130244984A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

　セラミドの産生を促進するための医薬品、化粧品等の提供。 （式中、Ｒ１は、ホスホノ基又は水素原子を示し、Ｒ２は、炭素数８～２４のアルキル基又は炭素数８～２４のアシル基を示し、Ｒ３は、Ｒ１がホスホノ基のとき炭素数１～２４のアルキル基を示し、Ｒ１が水素原子のときホスホノ基を示す。） で表される化合物又はその塩を有効成分とするセラミド産生促進剤。 　下記式（１）
PCT/JP2009/003605 2008-07-31 2009-07-30 セラミド産生促進剤 Ceased WO2010013474A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/001,701 US8440645B2 (en) 2008-07-31 2009-07-30 Ceramide production promoter
CN2009801205557A CN102438629A (zh) 2008-07-31 2009-07-30 神经酰胺产生促进剂
US13/870,315 US20130244984A1 (en) 2008-07-31 2013-04-25 Ceramide Production Promoter

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2008197958A JP5328254B2 (ja) 2008-07-31 2008-07-31 セラミド産生促進剤
JP2008-197958 2008-07-31
JP2008-197959 2008-07-31
JP2008197959A JP5527952B2 (ja) 2008-07-31 2008-07-31 セラミド産生促進剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/870,315 Continuation US20130244984A1 (en) 2008-07-31 2013-04-25 Ceramide Production Promoter

Publications (1)

Publication Number Publication Date
WO2010013474A1 true WO2010013474A1 (ja) 2010-02-04

Family

ID=41610188

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/003605 Ceased WO2010013474A1 (ja) 2008-07-31 2009-07-30 セラミド産生促進剤

Country Status (3)

Country Link
US (2) US8440645B2 (ja)
CN (1) CN102438629A (ja)
WO (1) WO2010013474A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2687580B1 (fr) * 2012-07-19 2018-04-11 Breitling AG Pièce d'horlogerie

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021323A1 (en) * 1991-05-31 1992-12-10 The Procter & Gamble Company Use of lysophosphate acids for the treatment of skin wrinkles
JPH0867621A (ja) * 1994-06-21 1996-03-12 Advanced Sukin Res Kenkyusho:Kk グリコサミノグリカン産生促進作用を有する皮膚活性化剤
JPH11139957A (ja) * 1997-11-06 1999-05-25 Nof Corp 浴用剤及び浴用剤組成物
JP2001192315A (ja) * 2000-01-07 2001-07-17 Kao Corp 皮膚弾力性改善剤
JP2002187817A (ja) * 2000-10-12 2002-07-05 Kao Corp 毛穴収縮剤
JP2007119361A (ja) * 2005-10-25 2007-05-17 Nagase Chemtex Corp ホスホリパーゼａ２阻害剤
JP2008105975A (ja) * 2006-10-24 2008-05-08 Kao Corp ケラチノサイト収縮剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
JPH07268387A (ja) 1994-03-29 1995-10-17 Kao Corp 洗浄剤組成物
EP0719542A4 (en) 1994-06-21 1998-02-04 Inst Advanced Skin Res Inc SKIN ACTIVATOR THAT SPEEDS UP GLUCOSAMINGLY CAN PRODUCTION
JPH10152421A (ja) 1996-11-22 1998-06-09 Kao Corp 毛髪のハリ、コシ及び感触を改善する方法
JP2001158736A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
JP2001158735A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 歯周病の予防及び改善剤
WO2002032392A1 (en) * 2000-10-12 2002-04-25 Kao Corporation Skin pore minimizers and skin elasticity improvers

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021323A1 (en) * 1991-05-31 1992-12-10 The Procter & Gamble Company Use of lysophosphate acids for the treatment of skin wrinkles
JPH0867621A (ja) * 1994-06-21 1996-03-12 Advanced Sukin Res Kenkyusho:Kk グリコサミノグリカン産生促進作用を有する皮膚活性化剤
JPH11139957A (ja) * 1997-11-06 1999-05-25 Nof Corp 浴用剤及び浴用剤組成物
JP2001192315A (ja) * 2000-01-07 2001-07-17 Kao Corp 皮膚弾力性改善剤
JP2002187817A (ja) * 2000-10-12 2002-07-05 Kao Corp 毛穴収縮剤
JP2007119361A (ja) * 2005-10-25 2007-05-17 Nagase Chemtex Corp ホスホリパーゼａ２阻害剤
JP2008105975A (ja) * 2006-10-24 2008-05-08 Kao Corp ケラチノサイト収縮剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MASAKI, H. ET AL.: "Lysophosphatidic acid is an effective agent for epidermal care", FRAGRANCE JOURNAL, vol. 37, no. 5, May 2009 (2009-05-01), pages 31 - 34 *
TANAKA, S. ET AL.: "Cyclic phosphatidate. Lipid mediator for controlling water content of the skin", FRAGRANCE JOURNAL, vol. 37, no. 4, April 2009 (2009-04-01), pages 97 - 102 *

Also Published As

Publication number Publication date
US8440645B2 (en) 2013-05-14
US20110105439A1 (en) 2011-05-05
US20130244984A1 (en) 2013-09-19
CN102438629A (zh) 2012-05-02

Similar Documents

Publication Publication Date Title
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
EP2444062A3 (en) Cosmetic product containing film-forming polymer
TN2014000042A1 (en) Cyclopropaneamine compound
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
TW200728307A (en) Novel spirochromanone derivatives
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
MX348228B (es) Cristal de derivados de 6,7-insaturado-7-carbamoil morfinano y metodo para producir el mismo.
TNSN08545A1 (en) Amino phosphate derivative and s1p receptor modulator having same as active ingredient
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
EP4230631A3 (en) Process for making trisubstituted silyloxyethyl triflates
WO2010034917A3 (fr) Mono ester de n-undecylenoyl phenylalanine et de polyol, procede pour sa preparation et utilisation desdits esters comme agent eclaircissant la peau
WO2010095768A8 (en) 4 -isopropylphenyl glucitol compounds as sglt1 inhibitors
NZ593102A (en) Dihydroetorphines and their preparation
MY147951A (en) Crystalline potassium salt of lipoxin a? analogs
WO2012153825A3 (en) Skin external preparation and method of producing same
WO2009014105A1 (ja) 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
WO2008133297A1 (ja) ジスキネジアの治療または予防剤
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
WO2008090717A1 (ja) Ａｄａｍ阻害剤
WO2008141097A9 (en) Stereoisomers propofol therapeutic compounds
EP2604261A3 (en) SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
MX2013005965A (es) Nuevos compuestos de triazol iii.
WO2013117869A3 (fr) Procédé de synthèse enzymatique de l'acide (7s)-3,4-dimethoxybicyclo [4.2.0]|octa-1,3,5-triene-7-carboxylique ou de ses esters, et application a la synthèse|de l'ivabradine et de ses sels
EP2597093A4 (en) BENZOFURANONE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREWITH
MX2013005568A (es) Derivado de sulfuro de difenilo y producto farmaceutico que contiene el mismo como ingrediente activo.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980120555.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09802723

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 13001701

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09802723

Country of ref document: EP

Kind code of ref document: A1